Skip To Main Content

Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS

Slowing of brain atrophy with teriflunomide and delayed conversion to clinically definite MS. This video is available for local use, dependent on local regulatory approval, for interactions with HCPs during calls/visits and digital engagements.

Sanofi Belgium, MAT-GLB-2200530